CLDX icon

Celldex Therapeutics
CLDX

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$36
40% upside
High target

2 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Barclays
Barclays
Etzer Darout
67% 1-yr CLDX win rate
17 Dec ‘25 1 month ago
Mizuho
Mizuho
Joseph Catanzaro
0% 1-yr CLDX win rate
21 Oct ‘25 2 months ago